Figure 5

Inhibition of antiangiogenesis assay by alginate bead in vivo. (A) Representative alginate beads from each group. (B) FITC-dextran uptake of beads from each group. The combination group showed a significant decrease in vascularization compared with the control groups(P < 0.05). The results were expressed as mean ± S.E. a: Ad-hEndo+ cisplatin; b: Ad-hEndo; c: cisplatin; d: Ad-null; e: NS.